President Trump's America First drug pricing policy aims to lower prescription drug prices by eliminating Pharmacy Benefit Managers (PBMs), exposing 340B abuse, and making Europe pay fair prices for American-developed drugs.
Key Points
Eliminating PBMs to reduce drug prices
Exposing 340B abuse through executive order
Pressuring Europe to pay fair market prices for American drugs
Pros
Lowering prescription drug prices for Americans
Increasing transparency in healthcare pricing
Holding European nations accountable for fair drug prices
Cons
Potential political bias as it is sponsored by Americans for Limited Government
Criticism of Biden for ditching Trump's rebate rule